Emily Dressler to Lung Neoplasms
This is a "connection" page, showing publications Emily Dressler has written about Lung Neoplasms.
Connection Strength
0.582
-
Foley KL, Dressler EV, Weaver KE, Sutfin EL, Miller DP, Bellinger C, Kittel C, Stone RJ, Petty WJ, Land SR, Spangler JG, Lesser GJ, Chiles C. The Optimizing Lung Screening Trial (WF-20817CD): Multicenter Randomized Effectiveness Implementation Trial to Increase Tobacco Use Cessation for Individuals Undergoing Lung Screening. Chest. 2023 Aug; 164(2):531-543.
Score: 0.163
-
Danhauer SC, Dressler EV, Brown WM, Nightingale CL, Brenes GA, Petty WJ, Curtis A, Murkutla S, Huang J, Wagi CR, Lesser GJ, Weaver KE. Reducing Anxiety and Dyspnea via Device-Guided Breathing (RELAX): A Multi-Site Feasibility Study in Post-Treatment Lung Cancer Survivors at Community Cancer Clinics (WF-01213). Integr Cancer Ther. 2023; 22:15347354231164406.
Score: 0.161
-
Bellinger C, Foley KL, Dressler EV, Kittel C, Miller DP, Weaver KE, Sutfin EL, Petty WJ, Spangler J, Stone R, Anderson DM, Kehn H, Steenstra C, Panikkar R, Chiles C. Organizational Characteristics and Smoking Cessation Support in Community-Based Lung Cancer Screening Programs. J Am Coll Radiol. 2022 Apr; 19(4):529-533.
Score: 0.152
-
Yan LZ, Dressler EV, Adams VR. Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimens. J Oncol Pharm Pract. 2018 Apr; 24(3):209-217.
Score: 0.107